- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.31 BnMarket Estimate, 2026
$1.37 BnMarket Forecast, 2034
$1.95 BnCAGR, 2026–2034
4.5%Executive Summary: Global Electrophoresis Reagents Market
- Market Scope: Comprehensive global analysis of the electrophoresis reagents sector, covering product types (gels, buffers, dyes), application categories (protein analysis, DNA/RNA analysis), end-user facilities, and regional distribution profiles.
- Market Valuation: Valued at USD 1.31 billion in 2025, reaching USD 1.37 billion in 2026, and projected to expand to USD 1.95 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2034.
- Primary Growth Drivers: Fast-growing aging population, increased government and private R&D funding for genomics and proteomics research, technological advancements, and rising prevalence of infectious diseases, cancer, and genetic disorders.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product | Gels (dominated market share backed by low operating costs and widespread utility in separating RNA, DNA, and proteins) | Buffers & Dyes (expanding steadily alongside rising molecular biology and clinical diagnostic testing requirements) |
| By Application | Protein Analysis (held the largest share driven by intensive pharmaceutical focus on proteomics research and biomarker discovery) | DNA & RNA Analysis (witnessing high-growth momentum propelled by infectious disease screening and genomics research) |
| By End-User | Pharmaceutical & Biotech Companies (secured the leading share due to heavy public/private R&D spending and drug development) | Hospitals & Diagnostic Centers (growing steadily with increased adoption of clinical chemistry and genetic testing workflows) |
| By Region | North America (market leader supported by highly developed healthcare infrastructure and high incidence of chronic diseases) | Asia-Pacific (predicted to register the fastest growth fueled by rising research activities, government investments, and adoption of advanced technology in China, Japan, and India) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive global life science and biotechnology landscape featuring established chemical and diagnostic corporations specializing in high-purity reagents and analytical instruments.
Key Companies: Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck Millipore, GE Healthcare, Agilent Technologies, Inc., Lonza Group AG, Takara Bio, Inc., and Harvard Bioscience, Inc.
Download Free Sample Report
Global Electrophoresis Reagents Market Size
The global electrophoresis reagents market was valued at USD 1.31 billion in 2025. The global market is anticipated to grow at a CAGR of 4.5% from 2026 to 2034 and be worth USD 1.95 billion by 2034 from USD 1.37 billion in 2026.
Electrophoresis is a laboratory technique for separating protein, RNA, or DNA molecules using an electric current. Agarose gels, TBE buffers, Bromophenol Blue, and Starch gels are the most common reagents used in electrophoresis, and various healthcare facilities employ electrophoresis for DNA and RNA analysis and protein analysis. Electrophoresis is used to analyze lipoproteins and apolipoproteins, which are essential for determining the severity of cardiovascular diseases and monitoring patients during treatment. Electrophoresis separates proteins depending on their size, purity, and density. This technique's ease of use allows it to be used in various applications, including hemoglobinopathies diagnosis, vaccination analysis, antibody analysis, and medicine quality control.
MARKET DRIVERS
The electrophoresis market has seen significant expansion, a fast-growing elderly population, increased funding for genomics research, and quick technological advancement in recent years, which has had a favorable impact on the overall growth of the global electrophoresis reagents market.
The market for electrophoresis reagents has seen new changes and novel applications. Increasing rates of infectious diseases, cancer, and genetic disorders are expected to boost research funding from local governments in several countries, as well as private funding from pharmaceutical and biotechnology companies, for the development of effective biologics for treating these diseases, which is expected to boost demand for electrophoresis reagents over the forecast period. In clinical laboratories, electrophoresis is used to measure lipoproteins utilizing enzymatic cholesterol and triglyceride labeling to diagnose CVD and other disorders.
In the near future, demand for electrophoresis reagents is likely to rise due to increased research and development activities in developing effective medicines. The global electrophoresis market is growing due to increased usage of next-generation sequencing, industry-academic cooperation, and increased government support for electrophoresis research. In addition, the opportunities for the market are created by rising demand for personalized treatment and a focus on proteomics research. The market for electrophoresis reagents is further predicted to grow in the future as the requirement for diagnostics grows due to the spread of chronic diseases.
MARKET RESTRAINTS
The advent of competing technologies offering higher efficiency and results and time-consuming processes, and limited sample analysis through gel electrophoresis are limiting the growth of this market to some extent. In addition, the electrophoresis reagents market has a challenge due to a lack of suitable rules and quality requirements for the manufacture of reagents. The growth of the electrophoresis reagents market is further expected to be hampered by a lack of suitable hospitals, doctors, research institutions, and pharmaceutical companies in low and middle-income nations, which are some of the product's key end customers.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product, Application, End-User, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Market Leaders Profiled | Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck Millipore, GE Healthcare, Agilent Technologies, Inc., Lonza Group, AG, Takara Bio, Inc., and Harvard Bioscience, Inc. |
SEGMENTAL ANALYSIS
By Product Insights
Based on the product, the gels segment led the global electrophoresis reagents market in 2024. Low operating and equipment costs, increased applications in the pharmaceutical and biotechnology industries, and the rising burden of infectious diseases, cancer, and genetic abnormalities are all propelling the gel segment. Gel electrophoresis is a technique for separating and analyzing macromolecules, including RNA, DNA, and proteins and their fragments, based on charge and size. It's used to separate proteins in clinical chemistry, and it's also used in molecular biology and biochemistry to separate a mixed population of RNA and DNA fragments by length, among other things. As a result of the factors mentioned, the segment is predicted to expand in the next few years.
By Application Insights
The protein analysis market held the largest share of the market in 2024. Factors can be ascribed to the pharmaceutical and biotechnology industries' increased attention on proteomics research. Because of the rising research and development efforts in the medical and pharmaceutical industries, protein analysis is expected to maintain its market dominance over electrophoresis.
By End-User Insights
Because of the increase in private and public R&D expenditure, the Pharmaceutical & Biotechnological Companies segment held the most outstanding share of the market. The Covid-19 epidemic and the introduction of new virus types are to blame. The ability of electrophoresis to separate DNA and RNA is critical in viral research and the development of effective antiviral treatments.
REGIONAL ANALYSIS
The fastest-growing market is predicted to be in Asia-Pacific. There has been an increase in the number of research activities going on in academic and research institutions, as well as pharmaceutical and biotechnology companies, in the emerging economies of China, Japan, and India, and increasing adoption of advanced technology and rising health awareness are some of the key factors contributing to market growth. For example, Japanese scientists have devised a new way to identify single virus particles based on changes in electrical current through the electrophoresis process. Furthermore, capillary electrophoresis in fields such as microbial detection and protein analysis is enhancing the popularity of the technology and propelling the market forward.
Because of the region's highly developed healthcare infrastructure, rising incidences of chronic and infectious diseases, and growing geriatric population, the North American segment is expected to dominate the electrophoresis reagents market with a market share during the forecast period.
Due to market players and research institutes' increased research and development initiatives, Europe is likely to see considerable growth in the electrophoresis reagents market.
KEY MARKET PLAYERS
Companies playing a leading role in the global electrophoresis reagents market profiled in this report are
- Sigma-Aldrich Corporation
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Merck Millipore
- GE Healthcare
- Agilent Technologies, Inc.
- Lonza Group AG
- Takara Bio, Inc.
- Harvard Bioscience, Inc.
GLOBAL ELECTROPHORESIS REAGENTS MARKET NEWS
- Hitachi High-Tech Corporation announced that the Hitachi DS3000 small capillary electrophoresis (CE) sequencer is now available for purchase through local agents in Japan, China, South Korea, and Taiwan. Hitachi High-Tech Corporation and Promega Corporation collaborated on the Hitachi DS3000, which was released in 2020.
- In 2021, capillary electrophoresis to be used to establish a rapid and cost-effective way of detecting recognized variations of concern, allowing local facilities to screen for and track SARS-CoV-2 variants of concern and adopt reactive treatments.
MARKET SEGMENTATION
This global Smartphone market research report is segmented and sub-segmented into the following categories.
By Product
- Dyes
- Gels
- Buffers
- Others
By Application
- Protein Analysis
- DNA & RNA Analysis
By End-User
- Academic & Research Institutions
- Pharmaceutical & Biotech Companies
- Hospitals & Diagnostic Centers
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa